Catalyst Wire Dossier Catalyst Wire Dossier

COTI-2

COTI-2 · Critical Outcome Technologies Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COTI-2, covering 2019-02-01 to 2019-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies [Phase 1]

See pricing